In early 2013, the Chinese government declared a war on air pollution and began instituting stringent policies to regulate the
Read more
Home » Lung Disease »
Botulinum toxin shows promise in trials to reduce post-operative atrial fibrillation (POAF) in cardiac surgery patients
Postoperative atrial fibrillation (POAF) is a common complication, affecting one quarter to one half of all patients following cardiac surgery.
Read more
Hypertonic saline may help babies with cystic fibrosis breathe better
Babies with cystic fibrosis may breathe better by inhaling hypertonic saline, according to a randomized controlled trial conducted in Germany
Read more
Aggressive prostate and lung cancers are driven by common mechanisms, researchers find
UCLA researchers have discovered a common process in the development of late-stage, small cell cancers of the prostate and lung.
Read more
Genetics and pollution drive severity of asthma symptoms: Finding may lead to a precision medicine approach in environmental health
Asthma patients, with a specific genetic profile, exhibit more intense symptoms following exposure to traffic pollution, according to researchers at
Read more
Overcoming a major barrier to developing liquid biopsies: A new study helps set standards for RNA sequencing, improving consistency and laying the foundation to move the field forward
The idea of testing blood or urine to find markers that help diagnose or treat disease holds great promise. But
Read more
Drug’s impact on amino acid transporter may offer non-small cell lung cancer patients new hope
An amino acid transporter named xCT may affect the growth and progression of non-small cell lung cancer, a discovery that
Read more
Stem cell therapy drug may protect against smoke-related COPD symptoms: Stem cell mobilization protects lung function in mouse study
A drug used in stem cell therapy to treat certain cancers may also protect against cigarette smoke-induced lung injury. The
Read more
Low vitamin D levels associated with scarring lung disease
Reviewing medical information gathered on more than 6,000 adults over a 10-year period, Johns Hopkins researchers have found that lower
Read more
Lung-on-a-chip simulates pulmonary fibrosis: New biotech could reduce time and cost of developing medicine for deadly lung disease
Developing new medicines to treat pulmonary fibrosis, one of the most common and serious forms of lung disease, is not
Read more